...
首页> 外文期刊>Bulletin of the Korean Chemical Society >Investigation of Tacrolimus Loaded Nanostructured Lipid Carriers for Topical Drug Delivery
【24h】

Investigation of Tacrolimus Loaded Nanostructured Lipid Carriers for Topical Drug Delivery

机译:他克莫司负载的局部脂质输送的纳米结构脂质载体的研究。

获取原文
获取原文并翻译 | 示例

摘要

The objective of this investigation was to develop nanostructured lipid carriers (NLCs) of tacrolimus by the hot homogenization technique by sonication. NLCs are commonly prepared by emulsification and lyophilization. The feasibility of fabricating tacrolimus-loaded NLCs was successfully demonstrated in this study. The developed NLCs were characterized in terms of their particle size, zeta potential, entrapment efficiency (EE) of tacrolimus, and morphology. Studies were conducted to evaluate the effectiveness of the NLCs in improving the penetration rate through hairless mouse skin. Tacrolimus-loaded NLCs were found to have an average size of 123.4 ± 0.3 nm, a zeta potential of -24.3 ± 6.2 mV, and an EE of 50%. In vitro penetration tests revealed that the tacrolimus-loaded NLCs have a penetration rate that is 1.64 times that of the commercial tacrolimus ointment, Protopic~R.
机译:这项研究的目的是通过超声热匀化技术开发他克莫司的纳米结构脂质载体(NLC)。 NLC通常通过乳化和冻干制备。这项研究成功证明了制备他克莫司负载的NLC的可行性。已开发的NLC的粒径,ζ电位,他克莫司的包封率(EE)和形态均经过了表征。进行了研究以评估NLC在提高无毛小鼠皮肤渗透率方面的有效性。发现他克莫司负载的NLC的平均大小为123.4±0.3 nm,ζ电位为-24.3±6.2 mV,EE为50%。体外渗透测试表明,装有他克莫司的NLC的渗透率是商用他克莫司软膏Protopic_R的1.64倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号